vs

Side-by-side financial comparison of NEOGENOMICS INC (NEO) and Stitch Fix, Inc. (SFIX). Click either name above to swap in a different company.

Stitch Fix, Inc. is the larger business by last-quarter revenue ($342.1M vs $186.7M, roughly 1.8× NEOGENOMICS INC). Stitch Fix, Inc. runs the higher net margin — -1.9% vs -57.9%, a 56.0% gap on every dollar of revenue. On growth, NEOGENOMICS INC posted the faster year-over-year revenue change (11.1% vs 7.3%). Over the past eight quarters, NEOGENOMICS INC's revenue compounded faster (6.5% CAGR vs 1.8%).

NeoGenomics Laboratories, Inc., also known as NeoGenomics or Neo, is an American CLIA-certified clinical laboratory, pharma services and information services company that specializes in cancer genetics diagnostic testing. The company's testing services include cytogenetics, fluorescence in situ hybridization (FISH), flow cytometry, immunohistochemistry, anatomic pathology, and molecular genetics.

Stitch Fix, Inc. is an online personal styling service in the United States. It uses recommendation algorithms and data science to personalize clothing items based on size, budget and style. The company was founded in 2011 and had an initial public offering in 2017 with a valuation of $1.6 billion. Stitch Fix generated $1.6 billion in net revenue in its fiscal year 2023, a decrease of 21% year-over-year and reported 3,297,000 active clients in September 2023. It is headquartered in San Franci...

NEO vs SFIX — Head-to-Head

Bigger by revenue
SFIX
SFIX
1.8× larger
SFIX
$342.1M
$186.7M
NEO
Growing faster (revenue YoY)
NEO
NEO
+3.8% gap
NEO
11.1%
7.3%
SFIX
Higher net margin
SFIX
SFIX
56.0% more per $
SFIX
-1.9%
-57.9%
NEO
Faster 2-yr revenue CAGR
NEO
NEO
Annualised
NEO
6.5%
1.8%
SFIX

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
NEO
NEO
SFIX
SFIX
Revenue
$186.7M
$342.1M
Net Profit
$-108.0M
$-6.4M
Gross Margin
43.3%
43.6%
Operating Margin
46.9%
-2.5%
Net Margin
-57.9%
-1.9%
Revenue YoY
11.1%
7.3%
Net Profit YoY
42.0%
-1.7%
EPS (diluted)
$-0.13
$-0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NEO
NEO
SFIX
SFIX
Q1 26
$186.7M
Q4 25
$190.2M
$342.1M
Q3 25
$187.8M
$311.2M
Q2 25
$181.3M
$325.0M
Q1 25
$168.0M
$312.1M
Q4 24
$172.0M
$318.8M
Q3 24
$167.8M
$319.6M
Q2 24
$164.5M
$322.7M
Net Profit
NEO
NEO
SFIX
SFIX
Q1 26
$-108.0M
Q4 25
$-6.4M
Q3 25
$-27.1M
$-8.6M
Q2 25
$-45.1M
$-7.4M
Q1 25
$-25.9M
$-6.5M
Q4 24
$-6.3M
Q3 24
$-17.7M
$-36.5M
Q2 24
$-18.6M
$-21.3M
Gross Margin
NEO
NEO
SFIX
SFIX
Q1 26
43.3%
Q4 25
43.8%
43.6%
Q3 25
42.8%
43.6%
Q2 25
42.6%
44.2%
Q1 25
43.6%
44.5%
Q4 24
44.9%
45.4%
Q3 24
44.6%
44.6%
Q2 24
44.1%
45.5%
Operating Margin
NEO
NEO
SFIX
SFIX
Q1 26
46.9%
Q4 25
-7.1%
-2.5%
Q3 25
-14.4%
-3.6%
Q2 25
-26.3%
-3.0%
Q1 25
-16.6%
-2.9%
Q4 24
-10.7%
-2.8%
Q3 24
-12.6%
-13.1%
Q2 24
-13.3%
-7.7%
Net Margin
NEO
NEO
SFIX
SFIX
Q1 26
-57.9%
Q4 25
-1.9%
Q3 25
-14.4%
-2.8%
Q2 25
-24.9%
-2.3%
Q1 25
-15.4%
-2.1%
Q4 24
-2.0%
Q3 24
-10.5%
-11.4%
Q2 24
-11.3%
-6.6%
EPS (diluted)
NEO
NEO
SFIX
SFIX
Q1 26
$-0.13
Q4 25
$-0.05
Q3 25
$-0.06
Q2 25
$-0.06
Q1 25
$-0.05
Q4 24
$-0.05
Q3 24
$-0.29
Q2 24
$-0.18

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NEO
NEO
SFIX
SFIX
Cash + ST InvestmentsLiquidity on hand
$146.1M
$244.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$828.8M
$204.1M
Total Assets
$1.3B
$530.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NEO
NEO
SFIX
SFIX
Q1 26
$146.1M
Q4 25
$159.6M
$244.2M
Q3 25
$164.1M
$234.9M
Q2 25
$154.7M
$234.2M
Q1 25
$346.2M
$219.1M
Q4 24
$367.0M
$253.3M
Q3 24
$362.0M
$247.0M
Q2 24
$355.1M
$244.5M
Total Debt
NEO
NEO
SFIX
SFIX
Q1 26
Q4 25
$341.9M
Q3 25
Q2 25
Q1 25
Q4 24
$541.1M
Q3 24
Q2 24
Stockholders' Equity
NEO
NEO
SFIX
SFIX
Q1 26
$828.8M
Q4 25
$836.6M
$204.1M
Q3 25
$838.3M
$203.0M
Q2 25
$854.0M
$200.4M
Q1 25
$888.3M
$197.8M
Q4 24
$902.3M
$190.5M
Q3 24
$908.2M
$187.0M
Q2 24
$915.9M
$208.9M
Total Assets
NEO
NEO
SFIX
SFIX
Q1 26
$1.3B
Q4 25
$1.4B
$530.7M
Q3 25
$1.4B
$480.6M
Q2 25
$1.4B
$484.7M
Q1 25
$1.6B
$472.6M
Q4 24
$1.6B
$507.1M
Q3 24
$1.6B
$486.9M
Q2 24
$1.6B
$537.0M
Debt / Equity
NEO
NEO
SFIX
SFIX
Q1 26
Q4 25
0.41×
Q3 25
Q2 25
Q1 25
Q4 24
0.60×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NEO
NEO
SFIX
SFIX
Operating Cash FlowLast quarter
$-8.1M
$10.9M
Free Cash FlowOCF − Capex
$5.6M
FCF MarginFCF / Revenue
1.6%
Capex IntensityCapex / Revenue
1.6%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$4.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NEO
NEO
SFIX
SFIX
Q1 26
$-8.1M
Q4 25
$1.3M
$10.9M
Q3 25
$8.9M
$7.0M
Q2 25
$20.3M
$20.5M
Q1 25
$-25.3M
$-16.2M
Q4 24
$9.8M
$14.3M
Q3 24
$9.2M
$8.2M
Q2 24
$13.9M
$21.7M
Free Cash Flow
NEO
NEO
SFIX
SFIX
Q1 26
Q4 25
$-6.5M
$5.6M
Q3 25
$570.0K
$2.8M
Q2 25
$14.0M
$16.0M
Q1 25
$-29.8M
$-19.4M
Q4 24
$-1.8M
$9.9M
Q3 24
$-1.6M
$4.5M
Q2 24
$814.0K
$18.9M
FCF Margin
NEO
NEO
SFIX
SFIX
Q1 26
Q4 25
-3.4%
1.6%
Q3 25
0.3%
0.9%
Q2 25
7.7%
4.9%
Q1 25
-17.8%
-6.2%
Q4 24
-1.0%
3.1%
Q3 24
-0.9%
1.4%
Q2 24
0.5%
5.9%
Capex Intensity
NEO
NEO
SFIX
SFIX
Q1 26
Q4 25
4.1%
1.6%
Q3 25
4.4%
1.4%
Q2 25
3.5%
1.4%
Q1 25
2.7%
1.0%
Q4 24
6.7%
1.4%
Q3 24
6.4%
1.2%
Q2 24
8.0%
0.9%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons